In ovarian cancers PI3K activation, occurring via either PIK3CA gene amplification/mutations or PTEN protein loss, has been reported by several studies [80–83] with the highest frequency in most malignant histotypes [84]. This evidence concerns the gene PIK3CA and ovarian cancer.